跳至主要内容
临床试验/NCT03250754
NCT03250754
已完成
不适用

Treatment of Headache Disorders With Acupuncture: Observational Study (HDACU)

Hospital Son Llatzer1 个研究点 分布在 1 个国家目标入组 482 人2017年3月20日

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Chronic Headache Disorder
发起方
Hospital Son Llatzer
入组人数
482
试验地点
1
主要终点
Number of days with headache per month
状态
已完成
最后更新
去年

概览

简要总结

Headache disorders (HDs), which are characterized by recurrent headache, constitute a public-health problem of enormous proportions, with an impact on both the individual sufferer and society. The stated goals of long-term headache treatment are to reduce the frequency, severity, and disability associated with acute attacks; decrease the reliance on poorly tolerated, ineffective, or unwanted acute pharmacotherapies; and avoid acute headache medication escalation. There is risk for adverse events, leading some patients to refuse prophylactic therapy. Acupuncture is widely used for the treatment of headaches and it may be applied as a single modality as well as part of a more complex treatment program. The objective of this study will be to investigate whether acupuncture in routine clinical practice ((Real World Data) is more effective than treatment of acute migraine attacks or routine care only in reducing headache frequency.

详细描述

A Cochrane systematic review published in 2016 concluded that acupuncture was at least as effective as, or possibly more effective than, preventive drug treatment for migraine prophylaxis with fewer side effects compared with conventional treatments . Cochrane reviews of tension-type headache conclude that acupuncture could be a valuable non-pharmacological tool in patients with frequent, episodic, and chronic tension-type headache. An observational, cross-sectional study, according to the STROBE guide, was conducted. The study was carried out in the Pain Service Unit of the Son Llàtzer University Hospital of Palma de Mallorca, Spain. Between January 2010 and December 2015, data from patients with chronic refractory headache, which did not respond to conventional treatment for at least 6 months, referred to the Pain Service Unit were examined to ascertain their eligibility.

注册库
clinicaltrials.gov
开始日期
2017年3月20日
结束日期
2018年4月30日
最后更新
去年
研究类型
Observational
性别
All

研究者

发起方
Hospital Son Llatzer
责任方
Principal Investigator
主要研究者

Javier Mata

Chief of Section of Anesthesiology and Reanimation Department

Hospital Son Llatzer

入排标准

入选标准

  • Clinical diagnosis of headache (\> 12 months) and at least two headaches per month (Physicians classified patients according to the criteria of the International Headache Society to differentiate between patients with, tension-type headache, trigeminal autonomic cephalgias (cluster headache and Horton's headache), trigeminal neuralgia, occipital neuralgia, cervicogenic headache and post-surgery headache).
  • Age ≥ 18 years.

排除标准

  • Headache caused by somatic diseases such as hypertension, meningioma or meningoencephalitis
  • Onset of headache less than 1-year before.
  • acupuncture treatment less than 1-year before

结局指标

主要结局

Number of days with headache per month

时间窗: At the end of the third month of treatment

Because the improvements observed were essentially proportional to the headache at study entry, we also calculated the percent reduction of headache days for each patient. Treatment responders were also calculated: a patient with a reduction of ≥ 50% was considered to be a treatment responder.

次要结局

  • Visual analogue scale (VAS) for pain(at baseline, 1 month and 3-months)
  • The change of headache days after 1 month(at baseline, 1 month and 3-months)
  • Assessment of satisfaction with treatment(at baseline, 1 month and 3-months)
  • Sleep quality assessment(at baseline, 1 month and 3-months)

研究点 (1)

Loading locations...

相似试验